Clinical Trials Directory

Trials / Completed

CompletedNCT03483922

HCC Screening Using DNA Methylation Changes in ctDNA

Clinical Trials on Detection of Hepatocellular Carcinoma With Non-invasive Method Based on DNA Methylation of Circulated Tumor DNA, PBMC and T Cells

Status
Completed
Phase
Study type
Observational
Enrollment
403 (actual)
Sponsor
HKGepitherapeutics · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Hepatocellular Carcinoma (HCC) is the fifth most common cancer world-wide. It is particularly prevalent in Asia, and its occurrence is highest in areas where hepatitis B is prevalent, indicating a possible causal relationship. Follow up of high-risk populations such as chronic hepatitis patients and early diagnosis of transitions from chronic hepatitis to HCC would improve cure rates. In most cases HCC is detected late resulting in increased mortality and morbidity. The purpose of this study is to develop and test non-invasive biomarkers based on methylation changes in PBMC and circulated tumor DNA in hepatocellular carcinomas patients.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTctDNA methylation in and it's Correlation wth Development and prediction of HCCBlood sample from patients with HCC, healthy individuals and individuals with hepatitis B will be collected, and DNA will extracted from PBMC and circulated tumor DNA will be subjected to bisulfite conversion. DNA from PBMC DNA will be analyzed with primers developed for the AHNAK-STAP1 genes. Plasma samples will be subjected to EZ direct DNA extraction and bisulfite conversion kit and will be amplified with primers developed to amplify the target regions. DNA will be used for the subsequent PCR amplification with specific primer to generate PCR amplicon for sequencing using a double PCR procedure. The product of PCR reaction will be subjected to indexed MiSeq Next-Generation sequencing that will allow us quantify DNA methylation level.

Timeline

Start date
2018-08-20
Primary completion
2020-06-01
Completion
2020-11-01
First posted
2018-03-30
Last updated
2024-07-05
Results posted
2024-07-05

Locations

1 site across 1 country: Bangladesh

Source: ClinicalTrials.gov record NCT03483922. Inclusion in this directory is not an endorsement.